BR9909867A - Composições estáveis contendo levosimendan e ácido algìnico - Google Patents

Composições estáveis contendo levosimendan e ácido algìnico

Info

Publication number
BR9909867A
BR9909867A BR9909867-9A BR9909867A BR9909867A BR 9909867 A BR9909867 A BR 9909867A BR 9909867 A BR9909867 A BR 9909867A BR 9909867 A BR9909867 A BR 9909867A
Authority
BR
Brazil
Prior art keywords
alginic acid
compositions containing
stable compositions
levosimendan
containing levosimendan
Prior art date
Application number
BR9909867-9A
Other languages
English (en)
Inventor
Ilkka Larma
Maarit Bockman
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BR9909867A publication Critical patent/BR9909867A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

"COMPOSIçõES ESTáVEIS CONTENDO LEVOSIMENDAN E áCIDO ALGìNICO" A presente invenção se relaciona a composições de levosimendam que contêm ácido algínico para aprimorar a estabilidade do levosimendan nas composições. O Levosimendam é útil no tratamento da deficiência cardiáca congestiva.
BR9909867-9A 1998-04-23 1999-04-23 Composições estáveis contendo levosimendan e ácido algìnico BR9909867A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (1)

Publication Number Publication Date
BR9909867A true BR9909867A (pt) 2000-12-19

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909867-9A BR9909867A (pt) 1998-04-23 1999-04-23 Composições estáveis contendo levosimendan e ácido algìnico

Country Status (33)

Country Link
US (1) US6531458B1 (pt)
EP (1) EP1079834B1 (pt)
JP (1) JP4475809B2 (pt)
KR (1) KR100590622B1 (pt)
CN (1) CN1165309C (pt)
AT (1) ATE231395T1 (pt)
AU (1) AU756338B2 (pt)
BG (1) BG64766B1 (pt)
BR (1) BR9909867A (pt)
CA (1) CA2329232C (pt)
CZ (1) CZ290911B6 (pt)
DE (1) DE69905034T2 (pt)
DK (1) DK1079834T3 (pt)
EA (1) EA002428B1 (pt)
EE (1) EE04143B1 (pt)
ES (1) ES2191426T3 (pt)
FI (1) FI980902A (pt)
GE (1) GEP20032942B (pt)
HK (1) HK1031998A1 (pt)
HR (1) HRP20000703B1 (pt)
HU (1) HUP0105446A3 (pt)
ID (1) ID26650A (pt)
IL (2) IL138950A0 (pt)
MX (1) MXPA00010368A (pt)
NO (1) NO318575B1 (pt)
NZ (1) NZ507455A (pt)
PL (1) PL192274B1 (pt)
PT (1) PT1079834E (pt)
RS (1) RS49955B (pt)
SK (1) SK284600B6 (pt)
TR (1) TR200003101T2 (pt)
WO (1) WO1999055337A1 (pt)
ZA (1) ZA200005630B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
WO2002064120A1 (fr) * 2001-02-13 2002-08-22 Taisho Pharmaceutical Co., Ltd. Preparations de gel a usage interne
US20080194567A1 (en) * 2005-03-14 2008-08-14 Piero Pollesello Combination Treatment for Enhancing Diuresis
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
AU555304B2 (en) * 1982-04-05 1986-09-18 Merck Sharp & Dohme Limited Stabilization of drugs in alginic acid and magnesium hydroxide granules
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
PL192274B1 (pl) 2006-09-29
EA002428B1 (ru) 2002-04-25
EP1079834A1 (en) 2001-03-07
CA2329232A1 (en) 1999-11-04
HK1031998A1 (en) 2001-07-06
NO20005312D0 (no) 2000-10-20
ES2191426T3 (es) 2003-09-01
SK284600B6 (sk) 2005-07-01
GEP20032942B (en) 2003-04-25
JP2002512964A (ja) 2002-05-08
IL138950A (en) 2006-08-20
HUP0105446A2 (hu) 2002-07-29
NZ507455A (en) 2002-02-01
AU756338B2 (en) 2003-01-09
CZ290911B6 (cs) 2002-11-13
DE69905034T2 (de) 2003-09-04
EA200001097A1 (ru) 2001-04-23
CN1165309C (zh) 2004-09-08
KR100590622B1 (ko) 2006-06-19
US6531458B1 (en) 2003-03-11
CZ20003779A3 (en) 2001-05-16
ID26650A (id) 2001-01-25
PL343722A1 (en) 2001-09-10
EE200000616A (et) 2002-06-17
ZA200005630B (en) 2002-01-14
CA2329232C (en) 2007-10-30
ATE231395T1 (de) 2003-02-15
NO318575B1 (no) 2005-04-11
DK1079834T3 (da) 2003-04-07
RS49955B (sr) 2008-09-29
NO20005312L (no) 2000-11-21
AU3524899A (en) 1999-11-16
BG64766B1 (bg) 2006-03-31
YU64000A (sh) 2002-12-10
JP4475809B2 (ja) 2010-06-09
EE04143B1 (et) 2003-10-15
EP1079834B1 (en) 2003-01-22
WO1999055337A1 (en) 1999-11-04
FI980902A (fi) 1999-10-24
CN1298303A (zh) 2001-06-06
HRP20000703A2 (en) 2001-04-30
KR20010072577A (ko) 2001-07-31
IL138950A0 (en) 2001-11-25
FI980902A0 (fi) 1998-04-23
HRP20000703B1 (en) 2009-11-30
TR200003101T2 (tr) 2001-01-22
BG104958A (en) 2001-07-31
SK15552000A3 (sk) 2001-05-10
MXPA00010368A (es) 2002-07-02
PT1079834E (pt) 2003-04-30
DE69905034D1 (de) 2003-02-27
HUP0105446A3 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
BR9808438A (pt) Composição de barra
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
BR9806296A (pt) Derivados de ácido sulfìnico e sua preparação e uso
ATE289332T1 (de) Silikongel enthaltend salizylsäure
BR9806752A (pt) Ftalazinonas.
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
CA2238465A1 (fr) Composes triaromatiques, compositions les contenant et utilisations
DK1007055T3 (da) Anvendelse af amifostin
BR9909867A (pt) Composições estáveis contendo levosimendan e ácido algìnico
DE69411726T2 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
DE69606321D1 (de) Stabilisiertes sonnenschutzmittel
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
BR9714049A (pt) Imidazopiridazinas
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
SE9003181D0 (sv) Use of heparin fraction
ES2173664T3 (es) Agentes cosmeticos.
ES2122184T3 (es) Utilizacion de derivados de la benzomorfolina en composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
ATA27199A (de) Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
BR7702389U (pt) Caixa de hidrÈmetro
BR8101162U (pt) Caneta escova
HRPK970026B1 (en) Olive resorbent

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/20, A61K 9/48, A61K 31/50, A61K 31/501, A61P 9/04

Ipc: A61K 9/20 (2009.01), A61K 9/48 (2009.01), A61K 31/

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE A MATERIA REIVINDICADA NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM ART. 13 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]